Columns
We will cover a variety of industry-related topics, including the future of clinical trials, with a focus on AI and DX.
Clinical Trials of the future
At the CRO where I used to work, each department head would take turns sending messages to all employees every week. Most department heads sent messages with serious content related to their work, encouraging and motivating employees. However, I was the only exception, and I was serializing a short science fiction novel on the theme of "clinical trials of the future." This novel is nearly five years old, and some of the stories have already been realized or are close to being realized, but I think it would be interesting if our company could aim in this direction in the future, so I plan to upload it regularly.
Will AI lead to desruptive innovation also in clinical development?
As in other industries, attempts to use AI to improve the effectiveness of pharmaceutical development are being actively undertaken, and concrete results have already been achieved in fields such as drug discovery and image diagnosis, which have already been computerized. Recently, attempts have been made to use AI to more quickly recruit patients for clinical trial site selection, and to use AI to synthtic control arm and compare them with the administration (treatment) group in clinical trials for rare diseases and cancer, where placebos have traditionally been used or where placebos could not be used for various reasons.
On the other hand, the use of AI in clinical trials, especially site monitoring and clinical data management, is still in its infancy, with the exception of a few cases. Our company focuses on solutions that improve and speed up clinical development, especially clinical trial operational efficiency, and is engaged in business such as introducing excellent products from overseas to Japan. Therefore, in this section, I would like to explain how effective the solutions we handle are in the appropriate situations.
